The Europe Biosimulation Market is expected to grow significantly from USD 3.5 billion in 2023 to USD 14.1 billion by 2032, at a CAGR of 16.90%. This growth is driven by advancements in biosimulation technologies, including AI, machine learning, and high-performance computing, alongside in